The Procter & Gamble Company (NYSE:PG - Get Free Report)'s share price traded down 0.1% during mid-day trading on Monday . The stock traded as low as $168.83 and last traded at $169.35. 971,485 shares changed hands during mid-day trading, a decline of 85% from the average session volume of 6,651,275 shares. The stock had previously closed at $169.54.
Analysts Set New Price Targets
Several research analysts have issued reports on the stock. DA Davidson lifted their target price on shares of Procter & Gamble from $159.00 to $160.00 and gave the stock a "neutral" rating in a report on Monday, October 21st. Barclays cut shares of Procter & Gamble from an "overweight" rating to an "equal weight" rating and set a $163.00 target price for the company. in a report on Monday, September 30th. TD Cowen assumed coverage on shares of Procter & Gamble in a report on Tuesday, July 23rd. They set a "buy" rating and a $189.00 price objective for the company. Piper Sandler assumed coverage on shares of Procter & Gamble in a research report on Tuesday, September 24th. They set a "neutral" rating and a $174.00 target price for the company. Finally, JPMorgan Chase & Co. boosted their target price on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an "overweight" rating in a research report on Thursday, September 19th. Nine analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $177.00.
View Our Latest Research Report on PG
Procter & Gamble Trading Up 1.1 %
The firm has a market cap of $403.56 billion, a PE ratio of 29.20, a P/E/G ratio of 3.67 and a beta of 0.42. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The company's 50 day moving average price is $170.32 and its two-hundred day moving average price is $168.40.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping analysts' consensus estimates of $1.90 by $0.03. The firm had revenue of $21.74 billion for the quarter, compared to analysts' expectations of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business's revenue for the quarter was down .6% on a year-over-year basis. During the same period in the prior year, the business posted $1.83 earnings per share. As a group, sell-side analysts forecast that The Procter & Gamble Company will post 6.94 EPS for the current year.
Procter & Gamble Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.35%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble's payout ratio is presently 69.48%.
Insiders Place Their Bets
In other Procter & Gamble news, CEO Jon R. Moeller sold 37,240 shares of the stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $168.89, for a total transaction of $6,289,463.60. Following the transaction, the chief executive officer now directly owns 263,537 shares in the company, valued at $44,508,763.93. This represents a 12.38 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Shailesh Jejurikar sold 10,623 shares of the stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total transaction of $1,797,624.06. Following the transaction, the chief operating officer now owns 23,890 shares in the company, valued at approximately $4,042,665.80. The trade was a 30.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 313,597 shares of company stock worth $53,268,499 in the last three months. Corporate insiders own 0.18% of the company's stock.
Institutional Trading of Procter & Gamble
A number of institutional investors have recently modified their holdings of the company. Itau Unibanco Holding S.A. purchased a new position in shares of Procter & Gamble in the 2nd quarter valued at approximately $28,000. Fairway Wealth LLC purchased a new position in shares of Procter & Gamble in the 2nd quarter valued at approximately $29,000. RPg Family Wealth Advisory LLC purchased a new position in shares of Procter & Gamble in the 3rd quarter valued at approximately $33,000. POM Investment Strategies LLC purchased a new position in shares of Procter & Gamble in the 2nd quarter valued at approximately $34,000. Finally, Quest Partners LLC purchased a new position in shares of Procter & Gamble in the 2nd quarter valued at approximately $36,000. 65.77% of the stock is currently owned by institutional investors.
Procter & Gamble Company Profile
(
Get Free Report)
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.